Clinical Trials Browser

Phase 2 × Oropharyngeal Neoplasms × atezolizumab × Clear all

NCT06254911 2026-01-27

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

Phase 2 Suspended

Oropharyngeal Neoplasms